首页 | 本学科首页   官方微博 | 高级检索  
     

参芪扶正注射液联合NP方案治疗晚期非小细胞肺癌的疗效观察
引用本文:耿丹,崔建春,马兰. 参芪扶正注射液联合NP方案治疗晚期非小细胞肺癌的疗效观察[J]. 中国实用医药, 2007, 2(5): 57-59
作者姓名:耿丹  崔建春  马兰
作者单位:1. 110016,沈阳,辽宁省人民医院肿瘤科
2. 110016,沈阳,辽宁省人民医院普外科
摘    要:目的观察参芪扶正注射液联合NP方案在晚期非小细胞肺癌(NSCLC)中的疗效。方法所有病例均经病理和(或)细胞学确诊为晚期NSCLC。其中:治疗组42例行长春瑞滨(NVB)加顺铂(DDP)方案化疗,同时加用参芪扶正注射液;对照组26例单用NP化疗。参芪扶正注射液250ml, d1-10;NVB25mg/m2,d1,d8;DDP:30mg/m2d2-4,均静脉滴注。结果治疗组和对照组的总RR分别为28.6%和19.2%(P=0.003),总临床受益率(CBR)分别为71.4%和61.5%(P=0.0032),中位进展时间分别为6.2个月和4.9个月(P=0.06),治疗组与对照组化疗后的生活质量(QOL)评分比较有明显提高(P=0.008),毒副反应亦较轻(P=0.006)。结论参芪扶正注射液能明显改善晚期NSCLC的RR、CBR、QOL,并且能增效减毒,具有良好的应用价值。

关 键 词:参芪扶正注射液  NP方案  化疗  非小细胞肺癌

The efficacy of Shenqifuzheng injection combined with NP for edvanced non-small cell lung cancer
GENG Dan,CUI Jian-chun,MA Lan. The efficacy of Shenqifuzheng injection combined with NP for edvanced non-small cell lung cancer[J]. China Practical Medical, 2007, 2(5): 57-59
Authors:GENG Dan  CUI Jian-chun  MA Lan
Abstract:Objective To observe the therapeutic efficacy of Shenqifuzheng injection for advanced non - small cell lung cancer.Methods There are two groups, group of Shenqifuzheng injection combined with NP, group of NP,68 cases of advanced non - small cell lung cancer. R-esults Group of Shenqifuzheng injection combined with NP had a better effect of raising the quality of life, improve the symptoms than group of NP (P < 0.05). Conclusion group of Shenqifuzheng injection combined with NP could improve the symptoms,alleviate the quality of life, reduced the toxicity of chemotherapy.
Keywords:Shenqifuzheng injection  NVB plus DDP  Non - small cell lung cancer  NSCLC
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号